Jean Marc Orgogozo

Summary

Country: France

Publications

  1. ncbi request reprint Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization
    J M Orgogozo
    Federation of Neurology, CHU Pellegrin, Bordeaux, France
    Neurology 61:46-54. 2003
  2. ncbi request reprint Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity
    Catherine Helmer
    INSERM U 593 Université de Bordeaux 2, Bordeaux, France
    Dement Geriatr Cogn Disord 22:87-94. 2006
  3. ncbi request reprint Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease
    Catherine Helmer
    INSERM U593, Universite de Bordeaux 2, Bordeaux, France
    Dement Geriatr Cogn Disord 23:168-74. 2007
  4. ncbi request reprint Advantages and disadvantages of neurological scales
    J M Orgogozo
    Department of Neurology, University Hospital Pellegrin, Bordeaux, France
    Cerebrovasc Dis 8:2-7. 1998
  5. ncbi request reprint Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)
    Jean Marc Orgogozo
    CHU Pellegrin, Bordeaux, France
    Stroke 33:1834-9. 2002
  6. ncbi request reprint [Anti-amyloid immunotherapy in Alzheimer's disease]
    J M Orgogozo
    Service de Neurologie, Universite de Bordeaux, Pole de Neurosciences Cliniques, CHU, Bordeaux
    Rev Neurol (Paris) 164:F95-7. 2008
  7. doi request reprint Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. a prospective population-based cohort
    Karine Pérès
    INSERM, U897, Université Victor Segalen Bordeaux2, Bordeaux, France
    J Alzheimers Dis 27:39-47. 2011
  8. ncbi request reprint The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study
    Helene Amieva
    INSERM Institut National de la Santé et de la Recherche Médicale Unit 593, Bordeaux, France
    Brain 128:1093-101. 2005
  9. ncbi request reprint Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study
    Karine Pérès
    Institut National de la Santé et de la Recherche Médicale U593, Bordeaux, France
    J Am Geriatr Soc 56:37-44. 2008
  10. ncbi request reprint Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community
    Laure Carcaillon
    INSERM, Unit 593, Bordeaux, France
    Dement Geriatr Cogn Disord 23:439-45. 2007

Detail Information

Publications27

  1. ncbi request reprint Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization
    J M Orgogozo
    Federation of Neurology, CHU Pellegrin, Bordeaux, France
    Neurology 61:46-54. 2003
    ..A Phase I study in AD patients demonstrated good safety and tolerability of multiple injections of aggregated Abeta42 (AN1792) with QS-21 as adjuvant...
  2. ncbi request reprint Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity
    Catherine Helmer
    INSERM U 593 Université de Bordeaux 2, Bordeaux, France
    Dement Geriatr Cogn Disord 22:87-94. 2006
    ..To analyze the prevalence of dementia by severity and to describe the sociodemographic characteristics of people with dementia in the community, as well as the consequences of this disease in terms of disability and institutionalization...
  3. ncbi request reprint Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease
    Catherine Helmer
    INSERM U593, Universite de Bordeaux 2, Bordeaux, France
    Dement Geriatr Cogn Disord 23:168-74. 2007
    ..To determine the predictive value of the 6-month evolution of the ADAS-cog score in initially mild to moderate Alzheimer's disease (AD) patients on the risk of death or severe dementia (MMSE <10) within 2 years...
  4. ncbi request reprint Advantages and disadvantages of neurological scales
    J M Orgogozo
    Department of Neurology, University Hospital Pellegrin, Bordeaux, France
    Cerebrovasc Dis 8:2-7. 1998
    ..They are powerful prognostic indicators in stroke. Most of them are equivalent, which allows comparison between studies...
  5. ncbi request reprint Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)
    Jean Marc Orgogozo
    CHU Pellegrin, Bordeaux, France
    Stroke 33:1834-9. 2002
    ....
  6. ncbi request reprint [Anti-amyloid immunotherapy in Alzheimer's disease]
    J M Orgogozo
    Service de Neurologie, Universite de Bordeaux, Pole de Neurosciences Cliniques, CHU, Bordeaux
    Rev Neurol (Paris) 164:F95-7. 2008
  7. doi request reprint Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. a prospective population-based cohort
    Karine Pérès
    INSERM, U897, Université Victor Segalen Bordeaux2, Bordeaux, France
    J Alzheimers Dis 27:39-47. 2011
    ..To conclude, women would report the first symptoms very early in the process by SMC, whereas men would tend to later report their difficulties and only in terms of IADL-restriction...
  8. ncbi request reprint The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study
    Helene Amieva
    INSERM Institut National de la Santé et de la Recherche Médicale Unit 593, Bordeaux, France
    Brain 128:1093-101. 2005
    ....
  9. ncbi request reprint Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study
    Karine Pérès
    Institut National de la Santé et de la Recherche Médicale U593, Bordeaux, France
    J Am Geriatr Soc 56:37-44. 2008
    ..To study the subtle changes in instrumental activities of daily living (IADLs) over the 10 years preceding the clinical diagnosis of dementia...
  10. ncbi request reprint Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community
    Laure Carcaillon
    INSERM, Unit 593, Bordeaux, France
    Dement Geriatr Cogn Disord 23:439-45. 2007
    ..Our study aimed at confirming the concept of fast decliners at the time of Alzheimer's disease (AD) diagnosis which best predicts mortality, in an unselected sample...
  11. ncbi request reprint Inhibitory breakdown and dementia of the Alzheimer type: a general phenomenon?
    Helene Amieva
    INSERM U330, University of Bordeaux II, Bordeaux, France
    J Clin Exp Neuropsychol 24:503-16. 2002
    ..However, no evidence was found for an impairment on the Go-No go task and only limited impairment on the Stop Signal task, suggesting that in the early stages of the disease, not all inhibitory mechanisms are uniformly impaired...
  12. pmc Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study
    Luc Letenneur
    INSERM, U897, Bordeaux, France
    PLoS ONE 3:e3637. 2008
    ....
  13. doi request reprint Short- versus long-term prediction of dementia among subjects with low and high educational levels
    Emilie Chary
    Universite Bordeaux, ISPED, centre Inserm U897, Bordeaux, France INSERM, centre Inserm U897, Bordeaux, France
    Alzheimers Dement 9:562-71. 2013
    ....
  14. ncbi request reprint Evidencing inhibitory deficits in Alzheimer's disease through interference effects and shifting disabilities in the Stroop test
    Helene Amieva
    INSERM U593, University of Bordeaux II, France
    Arch Clin Neuropsychol 19:791-803. 2004
    ....
  15. ncbi request reprint Inter-rater reliability of scales and tests used to measure mild cognitive impairment by general practitioners and psychologists
    Colette Fabrigoule
    Unité INSERM 330, Universite de Bordeaux 2, France
    Curr Med Res Opin 19:603-8. 2003
    ....
  16. doi request reprint Prodromal Alzheimer's disease: successive emergence of the clinical symptoms
    Helene Amieva
    Institut National de la Sante et de la Recherche Medicale, U897, France
    Ann Neurol 64:492-8. 2008
    ..Utilizing the long follow-up of the PAQUID study, we examined the emergence of the first clinical symptoms over a 14-year period of follow-up before the dementia phase of AD...
  17. doi request reprint Gender and education impact on brain aging: a general cognitive factor approach
    Cécile Proust-Lima
    Biostatistics Department, INSERM U897, Bordeaux Cedex 33076, France
    Psychol Aging 23:608-20. 2008
    ..Subjects with higher education exhibited a better mean score for the 4 tests, but this difference tended to attenuate with age for tests involving a speed component...
  18. ncbi request reprint Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study
    Helene Amieva
    INSERM Unit 593, Universite Victor Segalen, Bordeaux, France
    Dement Geriatr Cogn Disord 18:87-93. 2004
    ..Among the variables considered, the Letter Cancellation Test proved to be a major predictor of short-term conversion to dementia...
  19. ncbi request reprint Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
    Alistair Burns
    University of Manchester, Manchester, UK
    J Psychopharmacol 20:732-55. 2006
    ..Patients, their carers, and clinicians deserve to be optimistic in a field which often attracts therapeutic nihilism...
  20. ncbi request reprint Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study
    Howard H Feldman
    Division of Neurology, University of British Columbia Hospital, Vancouver, Canada
    Lancet Neurol 6:501-12. 2007
    ..To assess the effect of rivastigmine in patients with mild cognitive impairment (MCI) on the time to clinical diagnosis of Alzheimer's disease (AD) and the rate of cognitive decline...
  21. ncbi request reprint Moderate wine drinkers have lower hypertension-related mortality: a prospective cohort study in French men
    Serge C Renaud
    Hospital Emile Roux, Pavillon Buisson Jacob, 94456 Limeil Brévannes, France
    Am J Clin Nutr 80:621-5. 2004
    ..For a given blood pressure, the risk of death from coronary artery disease is much higher in northern Europe and the United States than in Mediterranean countries...
  22. ncbi request reprint Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke
    Michael Krams
    Pfizer Global Research and Development, Sandwich, UK
    Stroke 34:2543-8. 2003
    ..The prime objective was to determine the dose that gave a clinically relevant effect in patients...
  23. ncbi request reprint Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia
    Gustavo C Roman
    Department of Medicine Neurology, University of Texas HSC at San Antonio and the Audie Murphy Veterans Administration Hospital, Mail Code 7883, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Neurol Sci 226:81-7. 2004
    ..It would include specific disease entities such as post-stroke VCI, post-stroke VaD, CADASIL, Binswanger disease, and AD plus CVD. This category explicitly excludes isolated cognitive dysfunctions such as those mentioned above...
  24. ncbi request reprint Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease
    Rafael Blesa
    Hospital de la Sta Creu i Sant Pau, Barcelona, Spain
    Neurology 69:S23-8. 2007
    ..Preference for the patch may indicate reduced caregiver stress, substantiated by greater satisfaction and less interference with daily life. These benefits may lead to improved compliance...
  25. ncbi request reprint [Vascular risk factors and Alzheimer disease risk: epidemiological studies review]
    Pascale Cowppli-Bony
    INSERM U593, Universite de Bordeaux II
    Psychol Neuropsychiatr Vieil 4:47-60. 2006
    ..All these four vascular risk factors have variable interaction with the presence of cerebrovascular diseases and of the epsilon 4 allele of the apolipoprotein E gene which is a predisposition factor for sporadic AD...
  26. ncbi request reprint Third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelines: meeting report summary
    Vorapun Senanarong
    Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    Alzheimer Dis Assoc Disord 20:311-2. 2006
    ..The epidemiology studies of mild cognitive impairment and dementia in Asia were discussed at the meeting. The committee encouraged a collaborative research in the region in the future...
  27. ncbi request reprint Antiplatelet drug discontinuation is a risk factor for ischemic stroke
    Igor Sibon
    Fédération de neurosciences cliniques, CHU Bordeaux, France
    Neurology 62:1187-9. 2004
    ..0001). This temporal pattern has biologic plausibility because the inhibited platelets circulate in the blood for about 10 days...